Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Amy Wachholtz, Gerardo Gonzalez & Douglas Ziedonis. (2019) Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence. The American Journal of Drug and Alcohol Abuse 45:5, pages 495-505.
Read now
Read now
AntoineB. Douaihy, ThomasM. Kelly & Carl Sullivan. (2013) Medications for Substance Use Disorders. Social Work in Public Health 28:3-4, pages 264-278.
Read now
Read now
Walter Ling, Larissa Mooney, Min Zhao, Suzanne Nielsen, Matthew Torrington & Karen Miotto. (2011) Selective review and commentary on emerging pharmacotherapies for opioid addiction. Substance Abuse and Rehabilitation 2, pages 181-188.
Read now
Read now
Paolo Mannelli, Kathleen S Peindl & Li-Tzy Wu. (2011) Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Substance Abuse and Rehabilitation 2, pages 113-123.
Read now
Read now
Amy Wachholtz, Gerardo Gonzalez, Edward Boyer, Zafar N Naqvi, Christopher Rosenbaum & Douglas Ziedonis. (2011) Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Substance Abuse and Rehabilitation 2, pages 145-162.
Read now
Read now
Amy Wachholtz, Douglas Ziedonis & Gerardo Gonzalez. (2011) Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments. Substance Use & Misuse 46:12, pages 1536-1552.
Read now
Read now
AndrewA. Monte, Todd Mandell, BonnieB. Wilford, Joseph Tennyson & EdwardW. Boyer. (2009) Diversion of Buprenorphine/Naloxone Coformulated Tablets in a Region with High Prescribing Prevalence. Journal of Addictive Diseases 28:3, pages 226-231.
Read now
Read now
Evaristo Akerele, Adam Bisaga, Maria A. Sullivan, Fatima Garawi, Sandra D. Comer, Anil A. Thomas, Edward V. Nunes & Herbert D. Kleber. (2008) Dextromethorphan and Quinidine Combination for Heroin Detoxification. American Journal on Addictions 17:3, pages 176-180.
Read now
Read now
Alexander M. Ponizovsky & Alexander Grinshpoon. (2007) Quality of Life Among Heroin Users on Buprenorphine versus Methadone Maintenance. The American Journal of Drug and Alcohol Abuse 33:5, pages 631-642.
Read now
Read now
Paolo Mannelli, Edward Gottheil & ElisabethJ. Van Bockstaele. (2006) Antagonist Treatment of Opioid Withdrawal. Journal of Addictive Diseases 25:2, pages 1-8.
Read now
Read now
Articles from other publishers (52)
JoAnn Petrie, Logan R. Kowallis, Sarah Kamhout, Kyle B. Bills, Daniel Adams, Donovan E. Fleming, Bruce L. Brown & Scott C. Steffensen. (2023) Gender-Specific Interactions in a Visual Object Recognition Task in Persons with Opioid Use Disorder. Biomedicines 11:9, pages 2460.
Crossref
Crossref
Hongsong Feng, Rana Elladki, Jian Jiang & Guo-Wei Wei. (2023) Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks. Computers in Biology and Medicine 157, pages 106745.
Crossref
Crossref
Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian & Zurina Hassan. (2022) Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy. Neuroscience Letters 773, pages 136500.
Crossref
Crossref
Mohammad Mehdi Foroughi, Shohreh Jahani, Zahra Aramesh-Boroujeni, Motahare Vakili Fathabadi, Hasan Hashemipour Rafsanjani & Meisam Rostaminasab Dolatabad. (2021) Template-free synthesis of ZnO/Fe3O4/Carbon magnetic nanocomposite: Nanotubes with hexagonal cross sections and their electrocatalytic property for simultaneous determination of oxymorphone and heroin. Microchemical Journal 170, pages 106679.
Crossref
Crossref
Rima Atria Japarin, Nurul Hasnida Yusoff, Zurina Hassan, Christian P. Müller & Norsyifa Harun. (2021) Cross-reinstatement of mitragynine and morphine place preference in rats. Behavioural Brain Research 399, pages 113021.
Crossref
Crossref
E. Andrew Townsend, S. Stevens Negus & Matthew L. Banks. (2021) Medications Development for Treatment of Opioid Use Disorder. Cold Spring Harbor Perspectives in Medicine 11:1, pages a039263.
Crossref
Crossref
Norsyifa Harun, Illa Syafiqah Johari, Sharif Mahsufi Mansor & Mohammed Shoaib. (2019) Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats. Psychopharmacology 237:3, pages 855-867.
Crossref
Crossref
Shao-Cheng Wang, Yuan-Chuan Chen, Chun-Hung Lee & Ching-Ming Cheng. (2019) Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review. International Journal of Molecular Sciences 20:17, pages 4294.
Crossref
Crossref
Shaocheng Wang. (2018) Historical Review: Opiate Addiction and Opioid Receptors. Cell Transplantation 28:3, pages 233-238.
Crossref
Crossref
Mauricio Romero-Gonzalez, Abtin Shahanaghi, Gregory J. DiGirolamo & Gerardo Gonzalez. (2017) Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders. The American Journal on Addictions 26:8, pages 838-844.
Crossref
Crossref
Giordano de Guglielmo, Marsida Kallupi, Giulia Scuppa, Gregory Demopulos, George Gaitanaris & Roberto Ciccocioppo. (2016) Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents. Psychopharmacology 234:2, pages 223-234.
Crossref
Crossref
Mehrdad Salehi, Alireza Emadossadat, Gholam Reza Kheirabadi, Mohammad Reza Maracy & Mohammad Reza Sharbafchi. (2015) The Effect of Buprenorphine on Methamphetamine Cravings. Journal of Clinical Psychopharmacology 35:6, pages 724-727.
Crossref
Crossref
Gerardo Gonzalez, Gregory DiGirolamo, Mauricio Romero-Gonzalez, David Smelson, Douglas Ziedonis & Monika Kolodziej. (2015) Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug and Alcohol Dependence 156, pages 243-253.
Crossref
Crossref
Yung-Feng Yen, Pesus Chou, Yu-Shiuan Lin & Chung-Yeh Deng. (2015) Factors associated with health-related quality of life among injection drug users at methadone clinics in Taipei, Taiwan. Journal of the Chinese Medical Association 78:5, pages 292-298.
Crossref
Crossref
Javier A. Cepeda, Linda M. Niccolai, Alexandra Lyubimova, Trace Kershaw, Olga Levina & Robert Heimer. (2015) High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia. Drug and Alcohol Dependence 147, pages 196-202.
Crossref
Crossref
Amy Wachholtz, Simmie Foster & Martin Cheatle. (2015) Psychophysiology of pain and opioid use: Implications for managing pain in patients with an opioid use disorder. Drug and Alcohol Dependence 146, pages 1-6.
Crossref
Crossref
Amy Wachholtz & Gerardo Gonzalez. (2014) Co-morbid pain and opioid addiction: Long term effect of opioid maintenance on acute pain. Drug and Alcohol Dependence 145, pages 143-149.
Crossref
Crossref
Angelo Contarino. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse
379
390
.
. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse
293
390
.
Mohammad Javad Khodayar, Esmaeil Taherzadeh, Amir Siahpoosh, Zahra Mansourzadeh & Seyed Amir Hossein Tabatabaei. (2014) Thymus Daenensis Extract and Essential Oils Effects on Morphine Withdrawal Signs in Mice. Jundishapur Journal of Natural Pharmaceutical Products 9:3.
Crossref
Crossref
Phillip Oliver Coffin, Glenn‐Milo Santos, Moupali Das, Deirdre M. Santos, Shannon Huffaker, Tim Matheson, James Gasper, Eric Vittinghoff & Grant N. Colfax. (2013) Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial. Addiction 108:4, pages 751-761.
Crossref
Crossref
Randall S. Jotte. 2013. Emergency Medicine. Emergency Medicine
1653
1659.e1
.
Jose Martinez-Raga, Francisco Gonzalez-Saiz, Julian Oñate, Itziar Oyagüez, Eliazar Sabater & Miguel A Casado. (2012) Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain. Health Economics Review 2:1.
Crossref
Crossref
Larry Normansell & Jaak Panksepp. (2011) Glutamatergic modulation of separation distress: Profound emotional effects of excitatory amino acids in chicks. Neuroscience & Biobehavioral Reviews 35:9, pages 1890-1901.
Crossref
Crossref
Gui-Bin Wang, Liu-Zhen Wu, Peng Yu, Yi-Jing Li, Xing-Jie Ping & Cai-Lian Cui. (2011) Multiple 100Hz electroacupuncture treatments produced cumulative effect on the suppression of morphine withdrawal syndrome: Central preprodynorphin mRNA and p-CREB implicated. Peptides 32:4, pages 713-721.
Crossref
Crossref
Frederico C. Pereira, Bobby Gough, Tice R. Macedo, Carlos F. Ribeiro, Syed F. Ali & Zbigniew K. Binienda. (2009) Buprenorphine Modulates Methamphetamine-Induced Dopamine Dynamics in the Rat Caudate Nucleus. Neurotoxicity Research 19:1, pages 94-101.
Crossref
Crossref
Gerardo González & Mauricio Romero-González. (2010) Alternativas farmacológicas para el tratamiento de la dependencia a la heroína: un nuevo reto en Colombia. Revista Colombiana de Psiquiatría 39, pages 188S-212S.
Crossref
Crossref
Matthew W. Feltenstein, Phong H. Do & Ronald E. See. (2009) Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse. Psychopharmacology 207:3, pages 401-411.
Crossref
Crossref
Francesco Papaleo, Sandy Ghozland, Manuela Ingallinesi, Amanda J Roberts, George F Koob & Angelo Contarino. (2008) Disruption of the CRF2 Receptor Pathway Decreases the Somatic Expression of Opiate Withdrawal. Neuropsychopharmacology 33:12, pages 2878-2887.
Crossref
Crossref
David G. Lambert. (2008) The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nature Reviews Drug Discovery 7:8, pages 694-710.
Crossref
Crossref
John A. Tilelli. 2008. Pediatric Emergency Medicine. Pediatric Emergency Medicine
950
969
.
George A. Ricaurte, J. William Langston & Una D. McCANN. 2008. Neurology and General Medicine. Neurology and General Medicine
735
747
.
Jun-Xu Li, Lance R. McMahon & Charles P. France. (2007) Comparison of naltrexone, 6α-naltrexol, and 6β-naltrexol in morphine-dependent and in nondependent rhesus monkeys. Psychopharmacology 195:4, pages 479-486.
Crossref
Crossref
Danxin Wang, Xiaochun Sun & Wolfgang Sadee. (2007) Different Effects of Opioid Antagonists on μ-, δ-, and κ-Opioid Receptors with and without Agonist Pretreatment. Journal of Pharmacology and Experimental Therapeutics 321:2, pages 544-552.
Crossref
Crossref
L Cordonnier, M Sanchez, B P Roques & F Noble. (2007) Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments. British Journal of Pharmacology 151:1, pages 75-83.
Crossref
Crossref
Maria Esther Rodriguez-Rosas, Michelle R. Lofwall, Eric C. Strain, Danuta Siluk & Irving W. Wainer. (2007) Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. Journal of Chromatography B 850:1-2, pages 538-543.
Crossref
Crossref
Benedikt Fischer, Kate Kalousek, Jürgen Rehm, Jeff Powis, Mel Krajden & Jens Reimer. (2006) Hepatitis C, Illicit Drug Use and Public Health. Canadian Journal of Public Health 97:6, pages 485-488.
Crossref
Crossref
Mark D. Sullivan, Janis Leigh & Barak Gaster. (2006) Response to baca. Journal of General Internal Medicine 21:10, pages 1129-1129.
Crossref
Crossref
Wim van den Brink & Christian Haasen. (2006) Evidence-Based Treatment of Opioid-Dependent Patients. The Canadian Journal of Psychiatry 51:10, pages 635-646.
Crossref
Crossref
Hortensia Amaro, Sandra Arévalo, Gerardo Gonzalez, José Szapocznik & Martin Y. Iguchi. (2006) Needs and scientific opportunities for research on substance abuse treatment among Hispanic adults. Drug and Alcohol Dependence 84, pages S64-S75.
Crossref
Crossref
P Lobmaier, H Kornor, N Kunoe & A Bjørndal. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
S. Stevens Negus. (2006) Choice between Heroin and Food in Nondependent and Heroin-Dependent Rhesus Monkeys: Effects of Naloxone, Buprenorphine, and Methadone. Journal of Pharmacology and Experimental Therapeutics 317:2, pages 711-723.
Crossref
Crossref
M. C. Holden Ko, Mary F. Divin, Heeseung Lee, James H. Woods & John R. Traynor. (2006) Differential in Vivo Potencies of Naltrexone and 6β-Naltrexol in the Monkey. Journal of Pharmacology and Experimental Therapeutics 316:2, pages 772-779.
Crossref
Crossref
Joshua A. Lile, William W. Stoops, Todd M. Durell, Paul E. A. Glaser & Craig R. Rush. (2006) Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.. Experimental and Clinical Psychopharmacology 14:2, pages 136-147.
Crossref
Crossref
Joshua A. Lile. (2006) Pharmacological determinants of the reinforcing effects of psychostimulants: Relation to agonist substitution treatment.. Experimental and Clinical Psychopharmacology 14:1, pages 20-33.
Crossref
Crossref
Nicolas Joly, Anas El Aneed, Patrick Martin, Roméo Cecchelli & Joseph Banoub. (2005) Structural determination of the novel fragmentation routes of morphine opiate receptor antagonists using electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Rapid Communications in Mass Spectrometry 19:21, pages 3119-3130.
Crossref
Crossref
Joshua A Lile, William W Stoops, Andrea R Vansickel, Paul E A Glaser, Lon R Hays & Craig R Rush. (2005) Aripiprazole Attenuates the Discriminative-Stimulus and Subject-Rated Effects of D-Amphetamine in Humans. Neuropsychopharmacology 30:11, pages 2103-2114.
Crossref
Crossref
Camron D. Bryant, Paulette A. Zaki, F. Ivy Carroll & Christopher J. Evans. (2005) Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes. Clinical Neuroscience Research 5:2-4, pages 103-115.
Crossref
Crossref
Robert E Sorge, Heshmat Rajabi & Jane Stewart. (2005) Rats Maintained Chronically on Buprenorphine Show Reduced Heroin and Cocaine Seeking in Tests of Extinction and Drug-Induced Reinstatement. Neuropsychopharmacology 30:9, pages 1681-1692.
Crossref
Crossref
Danièle Debruyne, Thomas Quentin, Géraldine Poisnel, Véronique Lelong-Boulouard, Louisa Barré & Antoine Coquerel. (2005) Acute and chronic administration of clorazepate modifies the cell surface regulation of μ opioid receptors induced by buprenorphine in specific regions of the rat brain. Brain Research 1052:2, pages 222-231.
Crossref
Crossref
Kirsten M. Raehal, John J. Lowery, Castigliano M. Bhamidipati, Ryan M. Paolino, Jennifer R. Blair, Danxin Wang, Wolfgang Sadée & Edward J. Bilsky. (2005) In Vivo Characterization of 6β-Naltrexol, an Opioid Ligand with Less Inverse Agonist Activity Compared with Naltrexone and Naloxone in Opioid-Dependent Mice. Journal of Pharmacology and Experimental Therapeutics 313:3, pages 1150-1162.
Crossref
Crossref
S. L. Sell, L. R. McMahon, W. Koek & C. P. France. (2005) Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys. Behavioural Pharmacology 16:1, pages 53-58.
Crossref
Crossref